Screening for "Prelysosomal Disorders": Carbohydrate-Deficient Glycoprotein Syndromes
Open Access
- 1 November 1999
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 14 (1_suppl) , S16-S22
- https://doi.org/10.1177/0883073899014001041
Abstract
Physicians have become accustomed to thinking of certain inborn errors of metabolism (eg, lysosomal, peroxisomal, and mitochondrial diseases) as being associated with specific subcellular organelles. In recent years, a family of disorders of N-glycosylation has been recognized, in which the metabolic defect is expressed in the cytosol, endoplasmic reticulum, and Golgi apparatus. These could be conveniently thought of as "prelysosomal" disorders. At least six of these entities are characterized by hypoglycosylation of many glycoconjugates, and have been designated as the carbohydrate-deficient glycoprotein syndromes. Given the ubiquity of the products of N-glycosylation in the cellular economy, it is not surprising that these defects in metabolism have protean clinical manifestations. Delayed development and other neurologic symptoms are wedded to variable dysfunctions of the heart, liver, and endocrine and coagulation systems. Patients can have dysmorphic features or cerebellar hypoplasia, attesting to the antenatal expression of these disorders. The most frequently recognized phenotype (several hundred cases worldwide) has been designated carbohydrate-deficient glycoprotein syndrome type 1a, and results from mutations in phosphomannomutase, a cytosolic enzyme involved in the synthesis of the lipid-linked oligosaccharide that is eventually attached to nascent glycoproteins through the amide group of asparagine residues. All forms of carbohydrate-deficient glycoprotein syndrome express an excess of hypoglycosylated isoforms of circulating transferrin, which serves as a useful screening tool. Physicians should consider screening for carbohydrate-deficient glycoprotein syndrome in individuals with delayed development, seizures, strokelike episodes, cerebellar hypoplasia, and demyelinating neuropathy with or without other signs of multisystem disease. (J Child Neurol 1999;14(Suppl 1):S16-S22).Keywords
This publication has 29 references indexed in Scilit:
- A Novel Disorder of N-Glycosylation Due to Phosphomannose Isomerase DeficiencyBiochemical and Biophysical Research Communications, 1998
- Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.Journal of Clinical Investigation, 1998
- Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type IBlood Coagulation & Fibrinolysis, 1996
- Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type IFEBS Letters, 1995
- Carbohydrate-Deficient Glycoprotein Syndrome - A Fourth SubtypeNeuropediatrics, 1995
- Gonadal function and glycoprotein hormones in the carbohydrate‐deficient glycoprotein (CDG) syndromeActa Paediatrica, 1995
- Carbohydrate-deficient glycoprotein syndrome: electrophoretic study of multiple serum glycoproteinsBrain & Development, 1995
- Carbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type IIINeuropediatrics, 1993
- Diagnosis of the carbohydrate-deficient glycoprotein syndrome by analysis of transferrin in filter paper blood spotsActa Paediatrica, 1993
- Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.Journal of Clinical Investigation, 1981